×

Enrollment underway in Revance Therapeutics' late-stage DaxibotulinumtoxinA study

Published Apr 27 2021 at 12:35 PM GMT
Key
Points
  • Enrollment underway in Revance Therapeutics' late-stage DaxibotulinumtoxinA study.



Trending

Stats

  • Published Apr 27, 2021 12:35 PM GMT